The export bank's charter dies December 31. Its China-countering mandate is funded at 13 cents on the dollar.
Summary
The Export-Import Bank loses its authority to do new business at the end of this year unless Congress acts — with a 10-year Senate bill and a 5-year House draft pending. The scoreboard, from the bank's own documents: Congress ordered at least 20% of its $135 billion lending cap reserved for countering Chinese export finance — $27 billion — and the Inspector General found $3.6 billion of qualifying transactions in a year, over a third of it one deal. China's official export credit ran $15.3 billion to America's $4.7 billion in 2023 and grew 50% in 2024. Meanwhile the bank asks Congress to exempt its riskiest deals — nuclear and the China program itself — from the statutory 2% default cap that would freeze all new lending, while its default rate sits at 1.023% and it remits $120 million a year to the Treasury.
The documents
Five documents, read directly. The mandate audit is the Office of Inspector General's Review of 's China and Transformational Exports Program (August 2024). The competitive scoreboard is 's statutorily required Report to the U.S. Congress on Global Export Credit Competition (June 2025 edition, covering 2024). The bank's asks are in its FY2026 Congressional Budget Justification. The deadline and the freeze trigger are in the charter (12 U.S.C. 635 et seq.), and the chair's reauthorization request is on the congressional record.
The money
View data as table
| China, CY2023 | $15.3B | China Eximbank official MLT authorizations |
|---|---|---|
| United States, CY2023 | $4.7B | |
| China, CY2022 / CY2021 | ≈$11B / ≈$11B | |
| United States, CY2022 / CY2021 | $2.7B / $2.2B | |
| China 2024 trend | +50% | per EXIM's June 2025 Competitiveness Report; still half its 2015–19 average |
The 2019 reauthorization rebuilt the bank explicitly around this comparison, creating the China and Transformational Exports Program with a statutory instruction: establish a goal to reserve "at least 20 percent of the agency's total financing authority" — a fifth of the $135 billion cap, $27 billion — for transactions that neutralize Chinese export subsidies or advance ten "transformational" technology areas. The Inspector General measured the program against the mandate:
View data as table
| Congress's CTEP reservation goal | $27B | ≥20% of total financing authority, 2019 reauthorization |
|---|---|---|
| CTEP transaction value, FY2023 | $3.6B | 13% of the goal; largest single deal = 37% of the total |
| Default rate, end FY2025 | 1.023% | statute freezes new lending at 2% |
| Requested from Congress | default-cap exemption | for nuclear and CTEP transactions — the strategic deals |
The cross-examination
The bank's own filings argue both sides of its central claims.
Safe, or strategic? 's marquee fact is discipline: a 1.023 percent default rate against the statutory 2 percent that would freeze all new lending, $120.8 million remitted to the Treasury in FY2025, a forecast of $183.6 million in negative subsidy for FY2026 — "self-financing," in the budget justification's word. The same document asks Congress to exempt nuclear and CTEP transactions from the default-rate calculation, because "isolated" defaults on multi-billion-dollar strategic deals "could be sufficient to push the agency's portfolio-wide default rate above the cap." Both statements are true, and together they say the quiet part: the safe book is the one that isn't the mission, and the mission book doesn't fit under the safety statute. The low default rate that justifies reauthorization was earned by not doing the deals the reauthorization mandate demands.
The 20 percent that isn't. The 's review found FY2023 CTEP transactions of $3.6 billion — 13 percent of the $27 billion reservation goal — with one Angola transaction making up 37 percent of the total, and progress tracked in ways the found wanting. The U.S. figure China is measured against ($4.7 billion in 2023) counts the whole bank, not just CTEP. Meanwhile the 2025 Competitiveness Report records the other side accelerating: Chinese ECA activity up roughly 50 percent in 2024, its off-Arrangement lending nearly doubled in a year — and, the report notes, neither Chinese ECA responds to 's data requests, so even the scoreboard is an estimate.
The cliff has a history. The charter lapsed in 2015, and from 2015 to 2019 a quorumless board could approve nothing over $10 million — four years in which, as the 2019 debate documented, major exporters routed financing and production abroad. The current deadline replays that fight with the China program now the stated stake, a 10-year extension (S. 3772) and a 5-year House draft the live options, and six months on the clock.
What happens next
Reauthorization must move this fall — as standalone legislation or attached to a year-end vehicle — or new lending stops January 1. The open design questions are the ones the documents surface: whether the default-cap exemption rides along (converting the bank's risk posture by statute), whether the CTEP reservation becomes a requirement with teeth or stays a "goal," and whether the lending cap rises from $135 billion. The next Competitiveness Report, due June 2027, will score China's 2025-26 acceleration against whatever Congress decides.
The takeaway
- The deadline is real and the precedent is worse. A lapse doesn't wind the bank down; it freezes it mid-portfolio — the 2015–2019 episode is the documented base case.
- The safety record and the strategic mission are in tension by design. A 1% default rate under a 2% statutory cap is the product of a book that fills 13% of its China mandate; the exemption request is the bank saying so in its own budget.
- Watch what reauthorization changes, not whether it passes. Duration, the cap, the default-rate carve-out, and CTEP's goal-vs-requirement language are where the actual policy lives.
All figures are from the documents cited in-line, each read directly. "Self-financing" reflects FCRA accounting; fair-value accounting treatments of credit programs differ. Chinese ECA figures are 's estimates; China's ECAs do not respond to its data requests.
Sources
- Office of Inspector General, Review of 's China and Transformational Exports Program (Aug. 8, 2024) — the 20% reservation mandate, $3.6B FY2023 CTEP total, single-deal concentration, China $15.3B vs U.S. $4.7B (CY2023) MLT comparison. oversight.gov (PDF)
- , Report to the U.S. Congress on Global Export Credit Competition (June 2025) — $191.1B global MLT activity in 2024, Chinese ECA +50% growth, non-Arrangement ~$24B, non-response of Chinese ECAs. exim.gov (PDF)
- , 2026 Congressional Budget Justification (June 2025) — the default-cap exemption request for nuclear and CTEP deals, $10.9B authorization estimate, $183.6M negative subsidy forecast, $120.8M FY2025 Treasury remittance, $135B exposure cap. exim.gov (PDF)
- charter (12 U.S.C. 635 et seq.) — the December 31, 2026 sunset and 2% default-rate freeze. exim.gov
- Pending legislation — S. 3772 (10-year extension) and the House Financial Services discussion draft (5-year), as documented in the congressional record and reauthorization coverage; end-FY2025 default rate of 1.023%.
Comments
Always open. Logged-in readers can annotate paragraphs in place.
The finding, in one paragraph: the ninety-year-old agency that finances American exports is approaching its statutory cliff — no new business after December 31 absent reauthorization — carrying a set of contradictions its own filings document. It is profitable on the government's official accounting and remits cash to the Treasury, yet asks to stop counting its most strategic loans against the risk cap that governs it. Congress assigned it a fifth of its entire lending capacity to counter China, and the program holds 13 percent of that reservation, concentrated in single deals. And the competition it was rechartered in 2019 to answer is, per the bank's newest report to Congress, growing 50 percent a year again — while the bank's authority to answer expires in under six months.